Brind.

Butterfly Network, based in Chicago, received FDA clearance, and John Martin was appointed Chief Medical Officer at Cardiosense.

3 reports, 3 independent Updated Aug 13
Gone quiet Reached 3 outlets in its first 24 hours
Reports
3
Developments
2
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Butterfly Network, based in Chicago, received FDA clearance, and John Martin was appointed Chief Medical Officer at Cardiosense.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. John Martin joins Cardiosense; Butterfly Network receives FDA clearance.1 source
  2. John Martin appointed CMO Emeritus at Butterfly Network.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • MedTech DiveCardiosense appoints John Martin as chief medical officer This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter.
  • Business WireButterfly Network Advances AI-Powered Aortic Valve and Aorta Screening with New Research and Training Tools Results highlight the role of artificial intelligence development in enabling earlier detec
  • GuruFocus.comButterfly Network Inc (BFLY) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... Revenue: Record $23.4 million for Q2 2025, a 9% growth driven by higher average selling prices and inte